D E Furst
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 18
- Systemic Lupus Erythematosus Research 10
-
- Systemic Sclerosis and Related Diseases 12
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 3
- Dermatology top 2%
- Dermatologic Treatments and Research 7
- Immunology top 5%
-
- Chronic Lymphocytic Leukemia Research 5
-
- Inflammatory Myopathies and Dermatomyositis 4
-
- Diagnosis and Treatment of Venous Diseases 4
- Co-authors
- P. EmeryNathalie LambertPaul C. EvansSean MaloneyJ. Lee NelsonJames M. MooreMarco Matucci‐CerinicAlan J. Silman
- Journals
- Annals of the Rheumatic Diseases (10 papers)Cochrane Database of Systematic Reviews (5 papers)Lara D. Veeken (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
D E Furst
39 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 100
- Rheumatology 689
- Pathology and Forensic Medicine 538
- Hematology 291
- Dermatology 214
- Immunology 470
Countries citing papers authored by D E Furst
This map shows the geographic impact of D E Furst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Furst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Furst more than expected).
Fields of papers citing papers by D E Furst
This network shows the impact of papers produced by D E Furst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Furst. The network helps show where D E Furst may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D E Furst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 6 | |
| 2 | 2017 | 106 | |
| 3 | Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate | 2015 | 1 |
| 4 | Patient-Reported Outcomes Following 12 Months of Therapy with Abatacept (Plus Methotrexate or as Monotherapy) or Methotrexate and up to 6 Months after Treatment Withdrawal in Patients with Early Rheumatoid Arthritis | 2014 | 2 |
| 5 | The Impact on Anti-Citrullinated Protein Antibody Isotypes and Epitope Fine Specificity in Patients with Early RA Treated with Abatacept and Methotrexate. | 2014 | 4 |
| 6 | Sustained Improvements in Magnetic Resonance Imaging Outcomes with Abatacept Following the Withdrawal of All Treatment in Patients with Early Rheumatoid Arthritis | 2014 | 2 |
| 7 | Stringent Criteria for Low Disease Activity and Remission after 12 Months of Treatment, and after Treatment Withdrawal, with Abatacept Monotherapy, Abatacept with Methotrexate or Methotrexate Alone in Early Rheumatoid Arthritis | 2014 | 4 |
| 8 | 2014 | 168 | |
| 9 | “Flare” and disease worsening in rheumatoid arthritis: Time for a definition | 2009 | 9 |
| 10 | 2007 | 115 | |
| 11 | 2007 | 96 | |
| 12 | 2007 | 60 | |
| 13 | 2007 | 88 | |
| 14 | 2006 | 112 | |
| 15 | 2002 | 77 | |
| 16 | Safety Of Combination Therapy With Anakinra And Etanercept In Patients With Rheumatoid Arthritis. | 2001 | 23 |
| 17 | 2000 | 102 | |
| 18 | Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate. | 1993 | 18 |
| 19 | Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications. | 1988 | 20 |
| 20 | 1988 | 23 |
About D E Furst
D E Furst is a scholar working on Rheumatology, Dermatology, Pathology and Forensic Medicine, Hepatology and Genetics, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Sclerosis and Related Diseases (12 papers), Systemic Lupus Erythematosus Research (10 papers), Dermatologic Treatments and Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Inflammatory Myopathies and Dermatomyositis (4 papers), Diagnosis and Treatment of Venous Diseases (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). The work is most often cited by research in Rheumatology (689 citations), Pathology and Forensic Medicine (538 citations), Hematology (291 citations), Dermatology (214 citations) and Immunology (470 citations). D E Furst has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include P. Emery, Nathalie Lambert, Paul C. Evans, Sean Maloney, J. Lee Nelson, James M. Moore, Marco Matucci‐Cerinic, Alan J. Silman, George A. Wells and Janet Pope. Their work appears in journals such as Annals of the Rheumatic Diseases, Cochrane Database of Systematic Reviews, Lara D. Veeken, Arthritis Research & Therapy and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.